Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer

被引：3
|
作者：
Zhao, Zhengyi [1 ]
Cai, Shangli [1 ]
Wang, Zhijie [2 ]
机构：
[1] 3D Med Inc, Med Dept, Shanghai, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Pan Jia Yuan S Ln, Beijing 100021, Peoples R China
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 06期
关键词：
D O I：
10.1001/jamaoncol.2020.0283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：932 / 932
页数：1
相关论文
共 50 条
  • [31] Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer
    Sellahewa, Rav
    Moghaddam, Samar Masoumi
    Lundy, Joanne
    Jenkins, Brendan J.
    Croagh, Daniel
    PANCREAS, 2023, 52 (03) : e188 - e195
  • [32] Circulating tumor cells as prognostic marker in pancreatic cancer
    Yakar, Melek
    Etiz, Durmus
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (02):
  • [33] Thymidylate synthase (TS) expression as a prognostic molecular marker in stage II/III colon cancer
    Klingbiel, Dirk
    Missiaglia, Edoardo
    Yan, Pu
    Tejpar, Sabine
    Roth, Arnaud
    d'Ario, Giovanni
    Delorenzi, Mauro
    Bosman, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Circulating Tumor DNA in Stage II and III Melanoma
    Brunsgaard, Elise K.
    Bowles, Tawnya L.
    Asare, Elliot A.
    Grossmann, Kenneth
    Boucher, Kenneth M.
    Grossmann, Allie
    Jackson, Julie A.
    Wada, David A.
    Grandemange, Andrew
    Hyngstrom, John R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 392 - 393
  • [35] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 481 - 481
  • [36] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
    Tie, Jeanne
    Cohen, Joshua D.
    Lahouel, Kamel
    Lo, Serigne N.
    Wang, Yuxuan
    Kosmider, Suzanne
    Wong, Rachel
    Shapiro, Jeremy
    Lee, Margaret
    Harris, Sam
    Khattak, Adnan
    Burge, Matthew
    Harris, Marion
    Lynam, James
    Nott, Louise
    Day, Fiona
    Hayes, Theresa
    McLachlan, Sue-Anne
    Lee, Belinda
    Ptak, Janine
    Silliman, Natalie
    Dobbyn, Lisa
    Popoli, Maria
    Hruban, Ralph
    Lennon, Anne Marie
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Tomasetti, Cristian
    Gibbs, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2261 - 2272
  • [37] Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study
    Zheng, Peilin
    Chen, Qiaoxing
    Li, Jiake
    Jin, Canguang
    Kang, Lina
    Chen, Donghan
    JOURNAL OF SURGICAL RESEARCH, 2020, 245 : 475 - 482
  • [38] Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
    Suenaga, Yasuhito
    Kanda, Mitsuro
    Ito, Seiji
    Mochizuki, Yoshinari
    Teramoto, Hitoshi
    Ishigure, Kiyoshi
    Murai, Toshifumi
    Asada, Takahiro
    Ishiyama, Akiharu
    Matsushita, Hidenobu
    Tanaka, Chie
    Kobayashi, Daisuke
    Fujiwara, Michitaka
    Murotani, Kenta
    Kodera, Yasuhiro
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (01) : 17 - 27
  • [39] Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancer
    Kirchweger, P.
    Kupferthaler, A.
    Burghofer, J.
    Webersinke, G.
    Jukic, E.
    Schwendinger, S.
    Fuegger, R.
    Biebl, M.
    Wundsam, H.
    Rumpold, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S7 - S7
  • [40] Prognostic Significance of the Immunoscore in Colon Cancer in Stage III
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 114 - 114
12345